相似文献
1
Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
Cancer Lett. 2008 Jul 8;265(2):298-306. doi: 10.1016/j.canlet.2008.02.024. Epub 2008 Mar 19.
2
EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
Mol Cancer Ther. 2008 Oct;7(10):3176-86. doi: 10.1158/1535-7163.MCT-08-0526.
3
The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.
Breast Cancer Res Treat. 2011 Feb;126(1):27-36. doi: 10.1007/s10549-010-0873-4. Epub 2010 Apr 9.
4
Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.
Mol Cell Endocrinol. 2001 Apr 25;175(1-2):185-91. doi: 10.1016/s0303-7207(01)00387-2.
5
A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
Cancer Res. 2001 Jun 1;61(11):4467-73.
6
Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.
Br J Cancer. 2008 Mar 25;98(6):1132-40. doi: 10.1038/sj.bjc.6604261. Epub 2008 Feb 19.
7
Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
J Biol Chem. 2004 Jun 18;279(25):26126-33. doi: 10.1074/jbc.M314305200. Epub 2004 Apr 8.
8
Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines.
J Cell Physiol. 2000 Jun;183(3):321-9. doi: 10.1002/(SICI)1097-4652(200006)183:3<321::AID-JCP4>3.0.CO;2-O.
9
Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling.
Br J Cancer. 2005 Jan 17;92(1):140-6. doi: 10.1038/sj.bjc.6602257.
10
Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
J Cell Physiol. 2014 Nov;229(11):1831-41. doi: 10.1002/jcp.24637.
引用本文的文献
1
HER2-intronic miR-4728-5p facilitates HER2 expression and accelerates cell proliferation and migration by targeting EBP1 in breast cancer.
PLoS One. 2021 Feb 2;16(2):e0245832. doi: 10.1371/journal.pone.0245832. eCollection 2021.
2
A Disintegrin and Metalloproteinase 9 Domain (ADAM9) Is a Major Susceptibility Factor in the Early Stages of Encephalomyocarditis Virus Infection.
mBio. 2019 Feb 5;10(1):e02734-18. doi: 10.1128/mBio.02734-18.
3
Indolizine-Based Scaffolds as Efficient and Versatile Tools: Application to the Synthesis of Biotin-Tagged Antiangiogenic Drugs.
ACS Omega. 2017 Dec 31;2(12):9221-9230. doi: 10.1021/acsomega.7b01184. Epub 2017 Dec 27.
4
Transfer-RNA-mediated enhancement of ribosomal proteins S6 kinases signaling for cell proliferation.
RNA Biol. 2018;15(4-5):635-648. doi: 10.1080/15476286.2017.1356563. Epub 2018 Feb 1.
5
EBP1 protein modulates the expression of human MHC class II molecules in non-hematopoietic cancer cells.
Int J Oncol. 2015 Aug;47(2):481-9. doi: 10.3892/ijo.2015.3051. Epub 2015 Jun 16.
6
The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
Mol Cell Biochem. 2015 Jul;405(1-2):177-86. doi: 10.1007/s11010-015-2409-z. Epub 2015 Apr 17.
7
Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines.
Oncotarget. 2015 Feb 28;6(6):3932-46. doi: 10.18632/oncotarget.2846.
8
A computational strategy to select optimized protein targets for drug development toward the control of cancer diseases.
PLoS One. 2015 Jan 27;10(1):e0115054. doi: 10.1371/journal.pone.0115054. eCollection 2015.
9
The downregulation of ErbB3 binding protein 1 (EBP1) is associated with poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Mol Cell Biochem. 2014 Nov;396(1-2):175-85. doi: 10.1007/s11010-014-2153-9. Epub 2014 Aug 1.
10
P42 Ebp1 regulates the proteasomal degradation of the p85 regulatory subunit of PI3K by recruiting a chaperone-E3 ligase complex HSP70/CHIP.
Cell Death Dis. 2014 Mar 20;5(3):e1131. doi: 10.1038/cddis.2014.79.
本文引用的文献
1
Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
Cancer Res. 2006 Dec 1;66(23):11279-86. doi: 10.1158/0008-5472.CAN-06-2319.
2
Ebp1 is a dsRNA-binding protein associated with ribosomes that modulates eIF2alpha phosphorylation.
Biochem Biophys Res Commun. 2006 Jun 9;344(3):859-68. doi: 10.1016/j.bbrc.2006.03.205. Epub 2006 Apr 19.
3
Identification of Ebp1 as a component of cytoplasmic bcl-2 mRNP (messenger ribonucleoprotein particle) complexes.
Biochem J. 2006 May 15;396(1):99-107. doi: 10.1042/BJ20051548.
4
The ErbB3 binding protein Ebp1 interacts with Sin3A to repress E2F1 and AR-mediated transcription.
Nucleic Acids Res. 2005 Oct 27;33(18):6024-33. doi: 10.1093/nar/gki903. Print 2005.
5
ERBB receptors and cancer: the complexity of targeted inhibitors.
Nat Rev Cancer. 2005 May;5(5):341-54. doi: 10.1038/nrc1609.
6
Coexpression of the type 1 growth factor receptor family members HER-1, HER-2, and HER-3 has a synergistic negative prognostic effect on breast carcinoma survival.
Cancer. 2005 May 1;103(9):1770-7. doi: 10.1002/cncr.20970.
7
Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling.
Br J Cancer. 2005 Jan 17;92(1):140-6. doi: 10.1038/sj.bjc.6602257.
8
Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
J Biol Chem. 2004 Jun 18;279(25):26126-33. doi: 10.1074/jbc.M314305200. Epub 2004 Apr 8.
9
EBP1 is a nucleolar growth-regulating protein that is part of pre-ribosomal ribonucleoprotein complexes.
Oncogene. 2004 May 27;23(25):4454-65. doi: 10.1038/sj.onc.1207579.
10
Herstatin inhibits heregulin-mediated breast cancer cell growth and overcomes tamoxifen resistance in breast cancer cells that overexpress HER-2.
Oncogene. 2003 Nov 6;22(50):8178-86. doi: 10.1038/sj.onc.1206912.
Zotero 插件